First Phase Clinical Trial of Single Agent MBF-362 in Solid Tumors

NCT05940571 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Medibiofarma S.L.